Dubai (UAE), April 12, 2025 (ANI): On new antibiotic medicine tested by Wockhart, Wockhart Limited Executive Director Dr. Huzaifa Khorakiwala said, “Our blockbuster product, WCK 5222 ...

Zaynich, a combination of two powerful antibiotics Zidebactam and Cefepime (WCK 5222), helped treat a range of severe infections in the study, including hospital-acquired bacterial pneumonia (HABP ...

USFDA agreed to abridged clinical trial for phase III for Wockhardt's superdrug antibiotic WCK 5222," the company said in a filing to BSE. Advisory Alert: It has come to our attention that certain ...

"Trials are approved now, and we are becoming the world leader in antibiotic research, and blockbuster product WCK-5222-ZENIC has given a 97 per cent success in the phase-3 clinical trial ...